20/20 Biolabs, Inc.
NASDAQShorts in AIDX have beaten a rapid retreat this week, even as the stock itself continues to drift lower — a divergence that sets an unusual backdrop heading into the post-earnings period. The clearest story is the speed of the short-side unwind. Estimated short interest has fallen roughly 48% over the past week to around 16,400 shares, and is down nearly 50% from a month ago. That…
AIDX short sellers exit positions as shares borrowed plunge 48% in one week, cost to borrow falls to 34%.
Snapshot as of 16 May 2026
Shorts in AIDX have beaten a rapid retreat this week, even as the stock itself continues to drift lower — a divergence that sets an unusual backdrop heading into the post-earnings period. The clearest story is the…
AIDX heads into its May 15 earnings report as a study in contradictions: a fresh analyst endorsement, a borrow market that has dramatically eased, and a stock that has lost more than a quarter of its value in four…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AIDX — free to start on ORTEX.
Sign up for free →Open AIDX on ORTEX